The HPV vaccine can prevent more than 31,000 cancer cases a year. This is why I care so much.
Robin Mutz, chief nurse executive at St. Jude, has nearly 40 years’ experience in nursing and shares her story about why the HPV vaccine is so important.
One of my dear friends recently passed away because of treatment-related complications of stage 4 cervical cancer.
When her husband called me with the news, I knew what that meant. Every year in the United States, the human papillomavirus (HPV) causes 33,700 cancers in men and women. The HPV vaccine can prevent most of the cancers (about 31,200) from ever developing. Here’s are 5 things to know about HPV and cancer.
- The Centers for Disease Control and Prevention (CDC) recommends the HPV vaccine for boys and girls.
- HPV vaccination can be started as early as age 9, but is typically initiated at the adolescent check-up with other immunizations.
- Vaccination is also recommended for girls aged 13 through 26 years and boys aged 13 through 21 years who have not yet been fully vaccinated.
- More than 31,000 cases of cancer could be prevented with HPV vaccination each year. Getting vaccinated early protects children long before they’re exposed to HPV.
- While the HPV vaccine works best with adolescents, the FDA recently expanded its approval for use in males and females aged 27-45 who haven’t received the vaccine.
My dear friend never had the opportunity to receive the vaccine. When her son went to his physician to get the HPV vaccine, his doctor told him the vaccine was only for girls.
There is so much misinformation about HPV and the vaccine. As health care providers, we are obligated to educate our communities, health care providers, third party payors and legislators. Everyone should have the opportunity of many more reunion weekends, not have life halted from something that was preventable. We must stop HPV-related cancers. It’s preventable.
Related Posts
Recent Posts
How scientists visualize and analyze T cells
| Mar 21, 2023Scientists at St. Jude use a variety of tools to study T cells, including some they create themselves.
Learn moreMetastatic cancer cells thrive in harsh microenvironments
| Mar 16, 2023Like a journey through space, metastatic cells have to adapt to spread throughout the body.
Learn moreEngineering a new kind of therapy
| Mar 14, 2023Scientists at St. Jude are at the forefront of research to design and develop novel CAR T-cell therapies.
Learn moreData-driven science helps researchers design new protein interactions
| Mar 9, 2023With a comprehensive approach to thinking about data, St. Jude scientists are fueling progress.
Learn moreUnderstanding the complex networks behind a functional adaptive immune system
| Mar 7, 2023Explore how a T cell knows what it is, and what to do, through research happening at St. Jude.
Learn moreABOUT US
Sharing stories of the people, projects and progress being fueled by scientific advances at St. Jude Children’s Research Hospital.